HUNDREDS of women with ovarian cancer will benefit from a new NHS drug in the biggest breakthrough against the disease for ...

Ovarian cancer is a significant health concern for women in India. Many patients are diagnosed at advanced stages because ...

Ovarian cancer remains the deadliest gynecologic cancer, largely because it is rarely found early. Symptoms are often vague, and existing screening approaches—such as blood tests and transvaginal ...

Ovarian cancer, the third most frequent gynecologic cancer globally and the fifth leading cause of cancer death in women in the United States, is often called the “silent killer” in medical circles — ...

A blood sample does not have an obvious odor to a person in a lab coat. But to an electronic nose, it can carry a chemical signature that points toward disease. In a new study from Linköping ...

Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the disease spreads throughout the abdomen. Until now, scientists have never fully ...

AI models using ultrasound imaging demonstrate superior diagnostic performance for ovarian cancer compared to sonographers, with higher sensitivity and specificity. The study emphasizes the need for ...

Ovarian cancer is one of the deadliest gynecological cancers due to most of the cases—approximately 80 percent—being diagnosed in the late stages of the disease. 1 The standard of care for ovarian ...